FDA Addresses Lack of Clinical Trials Diversity in Draft Guidance


June 21, 2019

As seen on Outsourcing-Pharma.com – Posted June 21, 2019 – Original Article

 | By Melissa Fassbender | In a bid to increase clinical trial diversity, the FDA published a draft guidance suggesting sponsors rethink exclusion criteria, include children in adult studies when appropriate, use adaptive trials, and make sure other logistical barriers to participation are addressed.

Continued on Outsourcing Pharma